Our News And Views Resource Library About Our Firm Contact Us  

Services

Health Education

Health Promotion

Health Benefits - Design and Management

Communications

PBM Product Evaluation/Strategy

Publications/Tools

Pharmacy Contract Review

PBM Evaluation and Selection

Prescription Drug Prior Authorization Criteria

PBM Contract Management

Prescription Drug Claims Review and Analysis

Emerging Trends Identification and Risk Management

Healthcare is a dynamic business.

Dynamic - Drugs change, policies change, experimental treatments are developed, economic pressures change, etc. and the changes impact your plan and members. If a legislative change cuts payments for one group, costs are going to increase for another group. The introduction and marketing of a new drug will change demand in the entire drug category. Associates & Wilson stays ahead of the curve. We are on top of all the latest healthcare trends and developments and we analyze the impact. Our associates know where to look and what to do when they spot new movement.

Business – Just like any other business, healthcare is a business with the goal of making money. Those that don’t are history. Providers of products and services and healthcare players have business plans, marketing strategies, sales people, etc. The same rules that apply to purchasing other products or services should apply to purchasing healthcare, but often do not. The health plan generally specifies what’s covered (i.e. treating an illness or injury; standard’s based; effective for the member’s condition, etc.) but other purchasing parameters and evaluation metrics are required. Associates & Wilson has a deep understanding of how the drug industry works – how they introduce new products, keep old products profitable, extend patents by introducing new uses for a product, etc. We understand how PBMs and other healthcare players make money too. Our years of experience help us make accurate predictions and develop strategies to keep you on course.

“Sparks” is one of the services we provide to help you avoid potential pitfalls. On a routine basis, we “spark” ideas by presenting data from our myriad of sources and track emerging experience/utilization on identified drugs to monitor marketplace dynamics. Often our work comes first and changes in FDA regulation or industry policy follow our lead. Our proactive approach means you avoid the problem entirely and don’t waste time and money to clean it up after the fact. Here’s an example of how our attention to trends benefited the client and changed the marketplace.

Associates & Wilson realized that our client’s members were making an alarming number of claims for Neurontin, a drug approved for people with epilepsy. A far higher percentage of the members were taking Neurontin than were epileptic. This off-label use not only forced employers to pay for unnecessary medications, but placed members at medical risk from serious side effects. We investigated and discovered that doctors were prescribing Neurontin for a vast array of off-label uses at the urging of pharmaceutical company representatives. The off-label uses were not supported by scientific evidence. Soon after we began to crack down on Neurontin prescriptions, others began to follow our lead. Pfizer, Neurontin’s manufacturer, had to pay $430 million for false advertising charges. Associates & Wilson raised the issues and those with a resolve to protect their pocketbooks and the quality of patient care reaped rewards.

:: Top ::  

Site Map--Feedback--Privacy Policy--Terms Of Use